BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 34219323)

  • 1. RNA-binding protein SAMD4A inhibits breast tumor angiogenesis by modulating the balance of angiogenesis program.
    Zhou M; Wang B; Li H; Han J; Li A; Lu W
    Cancer Sci; 2021 Sep; 112(9):3835-3845. PubMed ID: 34219323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roquin2 suppresses breast cancer progression by inhibiting tumor angiogenesis via selectively destabilizing proangiogenic factors mRNA.
    Zhou M; Lu W; Li B; Yuan X; Liu M; Han J; Liu X; Li A
    Int J Biol Sci; 2021; 17(11):2884-2898. PubMed ID: 34345214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TARBP2 promotes tumor angiogenesis and metastasis by destabilizing antiangiogenic factor mRNAs.
    Zhou M; Lu W; Li B; Liu X; Li A
    Cancer Sci; 2021 Mar; 112(3):1289-1299. PubMed ID: 33484209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roquin1 inhibits the proliferation of breast cancer cells by inducing G1/S cell cycle arrest via selectively destabilizing the mRNAs of cell cycle-promoting genes.
    Lu W; Zhou M; Wang B; Liu X; Li B
    J Exp Clin Cancer Res; 2020 Nov; 39(1):255. PubMed ID: 33228782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RBMS2 inhibits the proliferation by stabilizing P21 mRNA in breast cancer.
    Sun X; Hu Y; Wu J; Shi L; Zhu L; Xi PW; Wei JF; Ding Q
    J Exp Clin Cancer Res; 2018 Dec; 37(1):298. PubMed ID: 30514345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA-binding protein RNPC1: acting as a tumor suppressor in breast cancer.
    Xue JQ; Xia TS; Liang XQ; Zhou W; Cheng L; Shi L; Wang Y; Ding Q
    BMC Cancer; 2014 May; 14():322. PubMed ID: 24884756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA-binding protein MSI2 isoforms expression and regulation in progression of triple-negative breast cancer.
    Li M; Li AQ; Zhou SL; Lv H; Wei P; Yang WT
    J Exp Clin Cancer Res; 2020 May; 39(1):92. PubMed ID: 32448269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MCPIP1 Selectively Destabilizes Transcripts Associated with an Antiapoptotic Gene Expression Program in Breast Cancer Cells That Can Elicit Complete Tumor Regression.
    Lu W; Ning H; Gu L; Peng H; Wang Q; Hou R; Fu M; Hoft DF; Liu J
    Cancer Res; 2016 Mar; 76(6):1429-40. PubMed ID: 26833120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of angiotensin II type 1 receptor in breast cancer cells induces epithelial-mesenchymal transition and promotes tumor growth and angiogenesis.
    Oh E; Kim JY; Cho Y; An H; Lee N; Jo H; Ban C; Seo JH
    Biochim Biophys Acta; 2016 Jun; 1863(6 Pt A):1071-81. PubMed ID: 26975580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-542-3p inhibits tumour angiogenesis by targeting angiopoietin-2.
    He T; Qi F; Jia L; Wang S; Song N; Guo L; Fu Y; Luo Y
    J Pathol; 2014 Apr; 232(5):499-508. PubMed ID: 24403060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 3'UTR of the pseudogene CYP4Z2P promotes tumor angiogenesis in breast cancer by acting as a ceRNA for CYP4Z1.
    Zheng L; Li X; Gu Y; Lv X; Xi T
    Breast Cancer Res Treat; 2015 Feb; 150(1):105-18. PubMed ID: 25701119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA Binding Protein RNPC1 Inhibits Breast Cancer Cell Metastasis via Activating STARD13-Correlated ceRNA Network.
    Zheng L; Zhang Z; Zhang S; Guo Q; Zhang F; Gao L; Ni H; Guo X; Xiang C; Xi T
    Mol Pharm; 2018 Jun; 15(6):2123-2132. PubMed ID: 29733656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of MDM2 inhibitors on vascular endothelial growth factor-mediated tumor angiogenesis in human breast cancer.
    Xiong J; Yang Q; Li J; Zhou S
    Angiogenesis; 2014 Jan; 17(1):37-50. PubMed ID: 23907365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of EIF5A2, via hypoxia or gene amplification, contributes to metastasis and angiogenesis of esophageal squamous cell carcinoma.
    Li Y; Fu L; Li JB; Qin Y; Zeng TT; Zhou J; Zeng ZL; Chen J; Cao TT; Ban X; Qian C; Cai Z; Xie D; Huang P; Guan XY
    Gastroenterology; 2014 Jun; 146(7):1701-13.e9. PubMed ID: 24561231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia induces miR-153 through the IRE1α-XBP1 pathway to fine tune the HIF1α/VEGFA axis in breast cancer angiogenesis.
    Liang H; Xiao J; Zhou Z; Wu J; Ge F; Li Z; Zhang H; Sun J; Li F; Liu R; Chen C
    Oncogene; 2018 Apr; 37(15):1961-1975. PubMed ID: 29367761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The oncoprotein HBXIP enhances angiogenesis and growth of breast cancer through modulating FGF8 and VEGF.
    Liu F; You X; Wang Y; Liu Q; Liu Y; Zhang S; Chen L; Zhang X; Ye L
    Carcinogenesis; 2014 May; 35(5):1144-53. PubMed ID: 24464787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastasis-Associated 1 (MTA1) Gene Expression Promotes Angiogenesis in Mouse Xenografts from Human Non-Small Cell Lung Cancer (NSCLC) Cells.
    Wang T; Li W; Huang H; Wang C
    Med Sci Monit; 2019 Jan; 25():484-491. PubMed ID: 30651530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual targeting of ANGPT1 and TGFBR2 genes by miR-204 controls angiogenesis in breast cancer.
    Flores-Pérez A; Marchat LA; Rodríguez-Cuevas S; Bautista-Piña V; Hidalgo-Miranda A; Ocampo EA; Martínez MS; Palma-Flores C; Fonseca-Sánchez MA; Astudillo-de la Vega H; Ruíz-García E; González-Barrios JA; Pérez-Plasencia C; Streber ML; López-Camarillo C
    Sci Rep; 2016 Oct; 6():34504. PubMed ID: 27703260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stemness marker ALDH1A1 promotes tumor angiogenesis via retinoic acid/HIF-1α/VEGF signalling in MCF-7 breast cancer cells.
    Ciccone V; Terzuoli E; Donnini S; Giachetti A; Morbidelli L; Ziche M
    J Exp Clin Cancer Res; 2018 Dec; 37(1):311. PubMed ID: 30541574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of microRNA-190 inhibits migration, invasion, epithelial-mesenchymal transition, and angiogenesis through suppression of protein kinase B-extracellular signal-regulated kinase signaling pathway via binding to stanniocalicin 2 in breast cancer.
    Sun G; Liu M; Han H
    J Cell Physiol; 2019 Aug; 234(10):17824-17838. PubMed ID: 30993707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.